Fig. 3From: A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary diseasePatient disposition. aOne patient was excluded due to improper MDI inhalation technique. BGF budesonide/glycopyrrolate/formoterol fumarate, COPD chronic obstructive pulmonary disease, MDI metered dose inhaler, PP per protocolBack to article page